CANDIDIASIS, INVASIVE

Clinical trials for CANDIDIASIS, INVASIVE explained in plain language.

Never miss a new study

Get alerted when new CANDIDIASIS, INVASIVE trials appear

Sign up with your email to follow new studies for CANDIDIASIS, INVASIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Terminated 1

Race for better fungal infection treatment halted early

Disease control Terminated

This study aimed to compare two different oral antifungal treatments for patients with serious Candida bloodstream or tissue infections. After receiving initial intravenous treatment, participants were randomly assigned to receive either oral ibrexafungerp or oral fluconazole. Th…

Matched conditions: CANDIDIASIS, INVASIVE

Phase: PHASE3 • Sponsor: Scynexis, Inc. • Aim: Disease control

Last updated Mar 18, 2026 14:41 UTC

CANDIDIASIS, INVASIVE

Get alerted when new CANDIDIASIS, INVASIVE trials appear

Race for better fungal infection treatment halted early